“Adaptive learning to address gaps in metastatic breast cancer treatment with CDK 4/6 inhibitors” Abstract

An abstract entitled “Adaptive learning to address gaps in metastatic breast cancer treatment with CDK 4/6 inhibitors” has been accepted for a poster presentation at the ASCO 2024 Quality Care Symposium in San Francisco on September 27-28. This project was in collaboration with Antidote Education and funded by Pfizer!

Register: https://conferences.asco.org/quality/attend

#ASCOQLTY24